期刊文献+

人参皂苷Rg1壳聚糖载药微球的研究 被引量:4

Research on Chitosan Nanoparticles with Ginsenoside Rgl
原文传递
导出
摘要 从复方中药抗癌散中提取得到人参皂苷Rg1,用壳聚糖与多聚磷酸钠采用离子交联法制备人参皂苷Rg1的纳米微球。考察了载药微球的包载性能及释放性能,结果表明,人参皂苷Rg1的载药微球能够被控制释放,且释放时间超过3d。 Ginsenoside Rgl was distilled from Chinese Traditional Medicine named Kangaisan.Nanopar- ticles with ginsenoside Rg1 were prepared based on ionic cross linking of chitosan and tripolyphosphate, and their encapsulation efficiency and release efficiency were investigated.Results showed that the nano- particles with ginsenoside Rg1 have controlled release property for more than 3 days.
出处 《武汉生物工程学院学报》 2008年第4期207-209,共3页 Journal of Wuhan Bioengineering Institute
关键词 人参皂苷RG1 壳聚糖载药微球 控制释药 ginsenoside Rg1 chitosan nanoparticles with drug control release of drug
  • 相关文献

参考文献6

  • 1Tarascon J MI,Aremand M.Synthesis of chitosan nanoparticles[].Nature.2001
  • 2Kawashima H I.Studied on in vitro metabolism of re- lated compounds[].Chemical and Pharmaceutical Bulletin.1985
  • 3Xu Yongmei.Study on chitosan crosslinked nanop- articles[].Intel J Pharm.2003
  • 4Daly M M.Research on new biomedical materials with chitosan[].Biotechnology Progress.1988
  • 5F.M.Gray.Polymer Electrolytes[].The Royal Society of ChemistryMaterials Monographs.1997
  • 6Kashyap,N.,Kumar,N.,Kumar,M. N.Hydrogels for pharmaceutical and biomedical applications[].Crit Rev Ther Drug Carr Syst.2005

同被引文献54

引证文献4

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部